Phase III study of ixekizumab in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis.
Phase of Trial: Phase III
Latest Information Update: 05 Apr 2016
At a glance
- Drugs Ixekizumab (Primary)
- Indications Erythrodermic psoriasis; Generalised pustular psoriasis; Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 05 Apr 2016 New trial record